Last reviewed · How we verify

NCT04387747

Evaluation of Sarcopenia in Patients With Stroke

Completed Last updated 30 June 2020
What this trial tests

trial testing SARCOPENIA IN STROKE PATIENTS in Sarcopenia in 81 participants. Completed in 1 June 2020.

Timeline
15 September 2019
Primary endpoint
1 June 2020
1 June 2020

Quick facts

Lead sponsorIstanbul Physical Medicine Rehabilitation Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment81
Start date15 September 2019
Primary completion1 June 2020
Estimated completion1 June 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

Who can join

Adults 40 to 80, any sex, with Sarcopenia or Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the prevalence of sarcopenia in stroke patients; to determine the relationship between sarcopenia and duration of stroke, age, gender, etiology of stroke, ambulation status, spasticity, nutrition and malnutrition

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

Other Istanbul Physical Medicine Rehabilitation Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04387747.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing